April 26, 2022

 

Central Drugs Standard Control Organization (CDSCO), the Drug Regulatory Agency of Government of India granted restricted emergency use authorization (EUA) to Bharat Biotech’s Covaxin as a COVID-19 vaccine to vaccinate children between the age of 6-12 years. Besides, the drug regulator also granted emergency use authorization to Corbevax (Biological E vaccine) for children between the age of 5-12 years and ZycovD (Zydus Cadila vaccine) for children above the age of 12 years. The information has also been tweeted by Health Minister Dr Mansukh Mandaviya.

The focus has shifted to children’s vaccines amid a fresh surge in Covid-19 cases, especially among children. The Government of India has been stating that 100 per cent vaccination is its top priority in its fight against coronavirus in the country. Accordingly, the government started the vaccination of children above 12 years of age on March 16. Currently, children between 12 and 14 years of age are being administered Corbevax.